A major crackdown on sellers of counterfeit drugs is being launched by the health ministry in Liberia. The low cost and availability of these drugs in rural areas make them attractive to Liberians, but the ministry and the nation's pharmaceutical board are sending envoys throughout the country to counsel people about the dangers of these counterfeit medicines. The global push to curb malaria is undermined by fake and ineffective drugs, Medicines and Health Products Regulatory Authority Managing Director David Sumo said. Drug resistance can be promoted by weak formulations of actual malaria drugs.
India is considering a proposal to include products with new drug delivery mechanisms, such as modified release and time-release, under the new drug category of rule 122 (E) of the Drugs and Cosmetics Act. Makers could be subject to additional regulatory monitoring as well as clinical studies, adding to the cost of drug development as well as the time needed to launch treatments.
More than half of the medical schools in Canada lack or have lax conflict-of-interest policies, according to a study published in PLoS One. Seventy percent of faculties had either permissive or nonexistent policies regarding interactions with sales representatives, and 82% of schools lacked or had permissive policies regarding product samples, but 88% had someone assigned to enforce disclosure, ghostwriting and gift policies.
Diversified Business Communications bought Pri-Med's U.S. business from M|C Holding, opening the door for the return of Pri-Med founder John Mooney and his former management. M|C Holding will continue to run Physicians Weekly and the Patient Education Center in the U.S. Pri-Med plans to offer medical education for hospitalists and other specialists, nurses, physician assistants, pharmacists and patients, according to Chief Operating Officer Lynn Long.